N. CABIOĞLU Et Al. , "Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer," CANCER RESEARCH , no.4, 2021
CABIOĞLU, N. Et Al. 2021. Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer. CANCER RESEARCH , no.4 .
CABIOĞLU, N., ÖNDER, S., Oner, G., Karatay, H., TÜKENMEZ, M., Muslumanoglu, M., ... Igci, A.(2021). Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer. CANCER RESEARCH , no.4.
CABIOĞLU, Neslihan Et Al. "Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer," CANCER RESEARCH , no.4, 2021
CABIOĞLU, Neslihan Et Al. "Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer." CANCER RESEARCH , no.4, 2021
CABIOĞLU, N. Et Al. (2021) . "Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer." CANCER RESEARCH , no.4.
@article{article, author={Neslihan CABIOĞLU Et Al. }, title={Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer}, journal={CANCER RESEARCH}, year=2021}